Current Status of Companion and Complementary Diagnostics: Strategic Considerations for Development and Launch
Sign Up to like & getrecommendations! Published in 2017 at "Clinical and Translational Science"
DOI: 10.1111/cts.12455
Abstract: US Food and Drug Administration (FDA)‐approved diagnostic assays play an increasingly common role in managing patients to prolong lifespan while also enhancing quality of life. Diagnostic assays can be essential for the safe and effective… read more here.
Keywords: companion; current status; strategic considerations; companion complementary ... See more keywords